PMID- 12296924
OWN - NLM
STAT- MEDLINE
DCOM- 20021213
LR  - 20190901
IS  - 0160-564X (Print)
IS  - 0160-564X (Linking)
VI  - 26
IP  - 10
DP  - 2002 Oct
TI  - The Medtronic Intact bioprosthesis: clinical and hemodynamic performance over 13 
      years.
PG  - 851-5
AB  - We evaluated our results over 13 years with the aortic-position Medtronic Intact 
      bioprosthesis. Our study involved 91 consecutive patients with isolated aortic 
      valve replacement with the Medtronic Intact bioprosthesis. The follow-up was 
      complete for 95%. Mean follow-up was 6.61 years (range 16 days-13 years), 590 
      patient years. Early mortality rate was 3.3%. Late mortality was 23 patients. 
      Survival at 13 years was 53.52% (SD = 7.63%). The linearized rate of major 
      thromboembolism was 0.34% per patient year; rate of major bleeding events was 
      0.33% per patient year. The rate of nonstructural dysfunction was 0.16% per 
      patient year. Rate of reoperation was 0.53% and rate of structural valve 
      deterioration was 0.16% per patient year. New York Heart Association (NYHA) 
      postoperative classes were I to II in 92.21%. Gradients were as follows: 21 to 
      23.87 mm Hg, 23 to 18 mm Hg, 25 to 15.5 mm Hg, and 27 to 16.50 mm Hg. Structural 
      valve deterioration was low during the 13 years of follow-up. Valve gradients and 
      areas remained the same over the follow-up period. The Medtronic Intact 
      bioprosthesis shows excellent clinical and hemodynamic performance at 13 years of 
      follow up.
FAU - de la Fuente, Anselmo
AU  - de la Fuente A
AD  - Department of Cardiac Surgery, Hospital de Navarra, Pamplona, Spain. 
      adelafuc@cfnavarra.es
FAU - Sanchez, Jose Ramon
AU  - Sanchez JR
FAU - Fernandez, Juan Luis
AU  - Fernandez JL
FAU - Romero, Javier
AU  - Romero J
FAU - Berjon, Jesus
AU  - Berjon J
FAU - Moriones, Ignacio
AU  - Moriones I
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Artif Organs
JT  - Artificial organs
JID - 7802778
SB  - IM
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Aortic Valve/*physiopathology/*surgery
MH  - *Bioprosthesis
MH  - Female
MH  - Follow-Up Studies
MH  - Heart Valve Diseases/mortality/*physiopathology/*surgery
MH  - *Heart Valve Prosthesis
MH  - Hemodynamics/*physiology
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Retrospective Studies
MH  - Survival Rate
MH  - Time Factors
MH  - Treatment Outcome
EDAT- 2002/09/26 06:00
MHDA- 2002/12/17 04:00
CRDT- 2002/09/26 06:00
PHST- 2002/09/26 06:00 [pubmed]
PHST- 2002/12/17 04:00 [medline]
PHST- 2002/09/26 06:00 [entrez]
AID - aor6984 [pii]
AID - 10.1046/j.1525-1594.2002.06984.x [doi]
PST - ppublish
SO  - Artif Organs. 2002 Oct;26(10):851-5. doi: 10.1046/j.1525-1594.2002.06984.x.